BioCatalystWatch
IBRXWorkspace / IBRX / OverviewCompany library
ImmunityBio, Inc. logo

ImmunityBio, Inc.

ImmunityBio, Inc. (IBRX)

Website

Featured programme · CD19 t-haNK

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

IL-15 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

IL-15 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

nogapendekin alfa inbakicept

IL-15 receptor

nogapendekin alfa inbakicept

IL-15 receptor

PreINDP1P2P3FilingApproved
hAd5-COVID-19

SARS-CoV-2 Spike (S) × SARS-CoV-2 Nucleocapsid (N)

PreINDP1P2P3FilingApproved
haNK

PreINDP1P2P3FilingApproved
recombinant BCG (rBCG)

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

nogapendekin alfa inbakicept

IL-15 receptor

Approved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IBRX PR & News

PR & News

IBRX SEC archive